AVR
Anteris Technologies Global Corp.NASDAQHealthcare$5.50+3.38%ClosedMarket Cap: $202.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-1394.34
P/S
105.77
EV/EBITDA
-2.08
DCF Value
$-1.37
FCF Yield
-39.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
70.3%
Operating Margin
24.4%
Net Margin
-4921.3%
ROE
-528.4%
ROA
-410.5%
ROIC
21.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $310.0K | 70.6% | $65.4M | $-29.2M | $-1.24 | — |
| FY 2025 | $1.9M | 70.3% | $467.0K | $-94.2M | $-4.00 | — |
| Q3 2025 | $429.0K | 71.3% | $-22.3M | $-22.2M | $-0.94 | — |
| Q2 2025 | $618.0K | 76.1% | $-20.9M | $-20.8M | $-0.89 | — |
| Q1 2025 | $556.0K | 62.8% | $-21.8M | $-21.9M | $-0.93 | — |
| Q4 2024 | $536.1K | 61.2% | $-21.1M | $-19.4M | $-0.82 | — |
| FY 2024 | $2.7M | 46.8% | $-78.4M | $-76.3M | $-3.77 | — |
| Q3 2024 | $769.0K | 42.3% | $-21.9M | $-21.9M | $-0.61 | — |
| Q2 2024 | $631.5K | 50.6% | $-18.9M | $-18.7M | $-0.52 | — |
| Q1 2024 | $766.0K | 38.3% | $-17.8M | $-16.4M | $-0.45 | — |
| Q4 2023 | $544.2K | 34.3% | $-15.9M | $-14.2M | $-0.39 | — |
| FY 2023 | $2.7M | 32.1% | $-48.1M | $-46.0M | $-1.28 | — |